Loading…
Astellas Pharma announced the construction of a new manufacturing facility for the active pharmaceutical ingredient of Prograf at its Toyama Technology Center in Japan. The total construction cost is approximately ¥10.0 billion, with construction starting in April 2020 and completion scheduled for August 2021.